No retraction, correction or concern found when last checked on Oct 27, 2026.

Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance

Corneliu Ovidiu Vrancianu, Laura Ioana Popa, Coralia Bleotu and 1 more

Frontiers in Microbiology · 2020 · Review · CC BY

doi:10.3389/fmicb.2020.00761

Abstract

Antimicrobial resistance (AMR) is a significant global threat to both public health and the environment. The emergence and expansion of AMR is sustained by the enormous diversity and mobility of antimicrobial resistance genes (ARGs). Different mechanisms of horizontal gene transfer (HGT), including conjugation, transduction, and transformation, have facilitated the accumulation and dissemination of ARGs in Gram-negative and Gram-positive bacteria. This has resulted in the development of multidrug resistance in some bacteria. The most clinically significant ARGs are usually located on different mobile genetic elements (MGEs) that can move intracellularly (between the bacterial chromosome and plasmids) or intercellularly (within the same species or between different species or genera). Resistance plasmids play a central role both in HGT and as support elements for other MGEs, in which ARGs are assembled by transposition and recombination mechanisms. Considering the crucial role of MGEs in the acquisition and transmission of ARGs, a potential strategy to control AMR is to eliminate MGEs. This review discusses current progress on the development of chemical and biological approaches for the elimination of ARG carriers.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 27, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

1The discovery of antibiotics and their clinical use is one of the greatest achievements in medical history. However, the acquisition and dissemination of antimicrobial resistance genes (ARGs) is a severe global problem that emerged in the post-antibiotic era. The acute limitation of currently available therapeutic options against common infections is responsible for increased rates of morbidity and mortality, longer treatment duration, higher hospitalization costs, and distrust in the efficacy of modern medical practices. The most common antimicrobial-resistant bacterial pathogens associated with nosocomial infections were initially gathered under the acronym “ESKAPE” (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), which was subsequently proposed to be updated to “ESCAPE” (E. faecium, S. aureus, Clostridium difficile, A. baumannii, P. aeruginosa, and Enterobacteriaceae).

2The phenomenon of antimicrobial resistance (AMR) is not new as ARGs have evolved over millions of years. However, AMR is amplified in the presence of the selective pressure exerted by antibiotics. Between 2000 and 2010, global antibiotic use increased by 36%, and in the case of carbapenems reached 45%. Inappropriate use of antibiotics in animals also contributes to rising AMR. The global consumption of antibiotics in animal feed was estimated to be 131,109 tons in 2013, and is expected to reach 200,235 tons in 2030. Incomplete microbe elimination, facilitated by microbiostatic drugs that inhibit multiplication of microbes without killing them, favors the development of drug resistance. Furthermore, incorrect administration of microbicidal drugs in terms of dosing intervals and concentration also contributes to the occurrence of AMR. The dosing interval is essential for antibiotics with a short elimination half-life, such as beta-lactams, tetracyclines, clindamycin, and the majority of macrolides; while concentration is a critical parameter for antibiotics such as vancomycin, aminoglycosides, azalides, ketolides, and quinolones. Genetic resistance of clinically significant pathogens is amplified by the ability of bacteria to form biofilms on viable tissues or inert substrates; these biofilms exhibit high phenotypic resistance or tolerance to high doses of antimicrobial agents. As a result of the selective pressure exerted by antibiotics, bacterial genomes are reshaping, and bacteria adapt and survive in the presence of antibiotics. There are multiple mechanisms of adaptation of resistant bacteria to antibiotics and elucidating these mechanisms will enable the development of effective novel therapies to tackle the increasing threat of resistance.

3An important strategy for combating AMR is to diminish the mobilization and persistence of ARGs in bacterial populations. This review highlights current progress in the development of chemical and biological approaches for the elimination of resistance plasmids. Such plasmids play a central role both in horizontal gene transfer (HGT) and as support for other mobile genetic elements (MGEs), in which ARGs are assembled through transposition and recombination mechanisms; the resulting MGEs can then move between chromosomes and plasmids or between plasmids. We will first describe the main MGEs involved in the global dissemination of antibiotic resistance, and then discuss current progress on the development of novel antimicrobial strategies aimed at elimination of MGEs, with a focus on resistance plasmids.

Role of MGEs in the Acquisition and Transmission of AMR

4Resistance to antimicrobials can be acquired through spontaneous mutations in chromosomal genes or by HGT of ARGs. The bacterial genome includes the genomic backbone or core genome, to which a variety of MGEs, termed the accessory genome, is added, and together this comprises the bacterial pan-genome. The term resistome refers to the part of the pan-genome that contains ARGs, both in commensal and pathogenic bacteria. Many ARGs can move between the bacterial chromosome and plasmids, within the same species or between different species or even genera, through different mobilization mechanisms (conjugation, transduction, and transformation) (Figure 1). HGT is the primary driver of multidrug resistance (MDR) in both Gram-negative and Gram-positive bacteria. MGEs (except for gene cassettes and miniature inverted-repeat transposable elements; MITEs) are DNA fragments encoding enzymes and other proteins that mediate intracellular or intercellular mobility. Intracellular mobility occurs within the same cell, from a chromosome to a plasmid or between plasmids. This type of mobility can be achieved by non-conjugative transposons, gene cassettes, and insertion sequence common region (ISCR) elements. These MGEs are mobilized by recombination but can involve replication. Intercellular mobility is achieved by MGE elements that are capable of self-replication and conjugative transfer, such as plasmids and conjugative transposons. The versatility of MGEs justified the replacement of the constant genome paradigm with that of the fluid genome.

5The majority of clinically significant ARGs are located on MGEs. To effectively fight AMR, we need to unravel the role of MGEs in the dissemination of antibiotic resistance among clinically important pathogens.

Plasmids

6Plasmids have a vital role in the accumulation and transfer of ARGs, mainly in Gram-negative bacteria, and are involved in the acquisition of resistance to most antibiotic classes, including β-lactams, aminoglycosides, tetracyclines, chloramphenicol, sulfonamides, trimethoprim, macrolides, polymyxins, and quinolones. Plasmids, either circular or linear, are stable replicons with a complex replication apparatus. Generally, plasmids are physically distinct from the primary bacterial chromosome and replicate independently; however, most of the components required for replication are provided by the host. Plasmids conferring MDR are usually conjugative, capable of initiating not only their own transfer but also that of other plasmids, and possess mechanisms to control their copy-number in the cell and/or replication ability. Plasmids guarantee transmission through different mechanisms like active partitioning systems, random segregation, or post-segregational killing. Besides conjugative plasmids, another category of plasmids are mobilizable plasmids, which are smaller in size and not self-transmissible, but they can transfer DNA to a particular host in the presence of conjugative plasmids; this transfer occurs both vertically and by HGT.

7The first classification of plasmids was based on incompatibility (Inc) groups (the mechanism that prevents the existence of plasmids with the same replication mechanism within the same bacterial cell); specific incompatibility groups were described in Enterobacteriaceae, Pseudomonas spp., and Gram-positive staphylococci. In MDR strains of P. aeruginosa, a series of plasmids (pS04 90, pBM41, p14057 A, and p14057 B) encoding carbapenemase resistance have been highlighted. Strains of A. baumannii show plasmid-encoded resistance to carbapenems, aminoglycosides (armA), colistin, sulfonamides, or streptomycin. In addition, plasmids conferring resistance to various classes of antibiotics have been found in Staphylococcus spp.. Resistance plasmids exhibit a high degree of plasticity, which is translated into an increased frequency of insertions, deletions, and changes in DNA. Plasmids may also harbor ARGs encoding efflux pumps that confer an MDR phenotype such as quinolone resistance.

8Further to their direct role in HGT, plasmids can also contribute to the acquisition and dissemination of ARGs to other MGEs in which ARGs are assembled via transposition and recombination mechanisms. Some of the MGE frequently involved in the acquisition of clinically relevant ARGs are briefly described below and summarized in Figure 2.

Insertion Sequences

9Insertion sequences (IS) are the smallest (0.7–2.5 Kb) and simplest transposable elements found in bacteria. These elements are usually flanked by short, mostly inverted repeats, which sometimes generate direct target duplications (DR) when they are integrated into the target DNA. IS differ from transposons by the absence of cargo or passenger genes, which are responsible for functions other than mobilization. Currently, there are more than 4500 IS listed in dedicated databases like ISFinder. IS are involved in AMR through their ability to transfer ARGs, but also by their ability to modulate the expression of ARGs; this occurs following integration of IS within the ARGs, or by the IS providing an active promoter for ARGs. For example, IS can increase expression of efflux pumps. The role of IS in antibiotic resistance has been highlighted by numerous studies, particularly those related to resistance to colistin and carbapenem. The most common mechanism for the development of colistin resistance is inactivation of the gene mgrB in K. pneumoniae, following the transposition of different types of IS, such as IS903, ISKpn26, IS10R, and IS5. In colistin-resistant strains of Klebsiella sp., alteration of mgrB and phoP gene sequences by different IS, such as ISKpn14, ISKpn28, IS903, IS5, and IS3, can sometimes induce a pandrug-resistance phenotype. IS also play a vital role in carbapenem resistance through a mechanism similar to that of colistin resistance but involving the inactivation of oprD and omp genes. The oprD gene is inactivated by the insertion of ISPpu-21. In addition to the IS themselves, there are other similar transposable elements (TEs) that harbor transposase genes (autonomous) or depend on host cell elements (non-autonomous). When IS elements are carrying passenger genes, they are termed IS transporters (tISs). In contrast to complex transposons that exist only as a single copy in a specific replicon, IS can be present as multiple copies, thus contributing to the accumulation of ARGs.

Resistance Transposons

10Transposons (Tn) are a category of MGEs that carry ARGs. Many Tn have the ability to jump from/to different locations in the genome, and are capable of mediating the mobility of both intramolecular and intermolecular ARG. Bacterial Tn can be divided into two types, composite (two IS elements flanking a central gene) and complex (containing the tnpA gene encoding transposase, the tnpR gene encoding resolvase, as well as one or more cargo genes). MITEs and palindrome-associated transposable elements (PATEs) are included in the category of non-autonomous derivatives. The predominant ARG-containing Tn whose transmission is a challenge when treating infections are Tn5 (encoding resistance to neomycin and kanamycin in A. baumannii and P. aeruginosa), Tn10 (encoding tetracycline resistance), Tn9, Tn903, Tn1525, and Tn2350.

Integrons

11Integrons are MGEs that have the ability to accumulate gene cassettes, including ARGs, and to disseminate them through other MGEs. Sedentary integrons are DNA elements found in the chromosomes of many species and were initially discovered due to their association with AMR. In contrast to sedentary integrons, mobile resistance integrons are often found in plasmids. The role of these elements in the acquisition and dissemination of ARGs is crucial, especially in Gram-negative bacteria, but they are also present in Gram-positive bacteria. Integrons contain the gene encoding integrase (IntI), an enzyme that allows the incorporation of circular DNA segments by site-specific recombination. They also harbor a specific integration site, at which one or more gene cassettes can be inserted by the integrase. Gene cassettes are usually small DNA fragments of 500–1000 base pairs, which can be mobilized by integrase. Generally, the gene cassettes comprise a single open reading frame (ORF) followed by a short recombination site termed attC (formerly “59 bases element”). Since the majority of these cassettes are promoterless, expression of their genes depends on the integron promoter. Gene cassettes contain ARGs encoding resistance to different antibiotic classes, as well as antiseptics and disinfectants. Integrons are divided into several classes (class 1, class 2, and class 3) depending on the amino acid sequence of the IntI enzyme. Class 1 integrons, which are typically associated with plasmids, are most commonly encountered in clinical isolates from hospitals and elderly care facilities, but have also been found in food production chain isolates (e.g., cattle farm isolates). ISCRs are transposable elements that are a similar size to IS elements, are often associated with class 1 integrons, and are capable of mobilizing adjacent DNA via a rolling-circle mechanism. When ISCR elements are associated with class 1 integrons, they form complex class 1 integrons.

Genomic Islands

12In addition to classical MGEs, such as conjugative plasmids or resistance transposons, an additional category of MGEs is a series of genomic islands that are capable of mediating their own excision, called integrative and conjugative elements (ICE). The concept of pathogenicity islands (PAIs) was first described in 1980 by who analyzed the virulence mechanisms of strains of E. coli isolated from urine cultures and observed the presence of unstable chromosomal regions bearing different virulence characteristics. Studies on multiple genomic islands have identified several common and essential features of these chromosomal regions: they are DNA segments with a size of 10–200 kb; they insert within tRNA genes; they contain directly repeated recognition sequences; and they contain cryptic genes encoding factors involved in integration, insertion, or transfer.

Integrative and Conjugative Elements

13Integrative and conjugative elements (ICE) were first described in 1946 by, and are responsible for HGT of most resistance and virulence factors. ICE are 18–600 kbp in size and share several common characteristics with genomic islands, including insertion at a specific site, association with phage integrase genes, and being flanked by inverted repeats. Excision and integration of ICE are accomplished through a recombinase, often termed an integrase. The integrases associated with ICE are tyrosine or serine recombinases, and are homologous to the integrases found in temperate phages. The insertion site for ICE in the bacterial chromosome is attB and is usually located in the gene encoding tRNA, hence the ICE attachment site is termed att. Some ICE have low specificity for the att site, and thus may have an affinity for other sites. Similar to conjugative plasmids, the excision and transfer of ICE are mediated by a type IV secretion system, but in contrast to the conjugative plasmids, which are capable of autonomous replication, ICE integrate into the chromosome and replicate with it. However, some ICE are capable of autonomous plasmid-like replication. When ICE are mobilizing bacterial DNA, such as genomic islands, they are termed integrative mobilization elements (IME). In terms of ICE conjugation, the transfer mechanism is similar to that encountered in plasmids. In the case of plasmids, the relaxase enzyme binds to the DNA and introduces a break in oriT to initiate rolling-circle replication. Relaxase remains bound to the single-stranded DNA and forms a complex with a specific coupling protein that allows the translocation of DNA into the recipient cell. ICE mediate the acquisition of genes conferring selective advantages such as resistance to antibiotics or heavy metals, degradation of some compounds, increased bacterial fitness, ability to achieve symbiosis, use of alternative carbon sources, expression of virulence factors such as type III and IV secretion systems, which play an essential role in regulating contact with host cells, disruption of signal transduction, or promotion of apoptosis.

14Integrative and conjugative elements play a vital role in the acquisition and intercellular transmission of ARGs. Through their own integration and mobilization apparatus, these elements have the ability to mobilize adjacent sequences, including genomic islands or composite transposons carrying ARGs. Examples include Tn10 found in ICEHpaT3T1 from Haemophilus parainfluenzae and ICEHin1056 from H. influenzae, containing tetracycline and chloramphenicol resistance genes; R391, a plasmid of the SXT ICE family that carries kanamycin resistance genes, and ICEPmiJpn1 described in Proteus mirabilis and encoding resistance to broad-spectrum beta-lactamases. There are also a number of ICE encountered in H. influenzae (ICEHin1056, ICEHin299, ICEHin2866, ICEHpa8f, ICEHin028, ICEHinB). ICEEc2, identified in E. coli, contains Tn7, which can be mobilized independently, and class 2 integrons. Tn7 carries dfrA1, sat2, and aadA1, which are responsible for resistance to trimethoprim, streptothricin, and streptomycin/spectinomycin, respectively. Another large ICE family is ICETn4371 found in Beta- and Gamma-Proteobacteria. Members of this ICE family, such as ICETn43716061 found in P. aeruginosa, display transfer mechanisms similar to IncP plasmids and carry different ARGs. The Tn21 transposon subfamily, containing pKLC102/PAPI-1 and PAGI-2/PAGI-3 (P. aeruginosa-pathogenicity island-type ICE) carbapenem resistance genes are integrated into tRNALys and tRNAGly. The Tn4371 family in P. aeruginosa (e.g., ICETn43716061) also carries carbapenem ARGs. Tn916-type elements that encode tetracycline or minocycline resistance, via the tet(M) gene, may embed additional ARGs for other antibiotics such as macrolides, lincosamides, and streptogramins (MLS) and kanamycin/neomycin in the case of Tn1545. observed that the majority of transposable elements, including composite transposons, mobilizable transposons, ICE, and genomic islands, possess similar transposition mechanisms (serine or tyrosine recombinases). Consequently, it was suggested that all these elements capable of integration and conjugation should be called conjugative transposons, even though most of them integrate into a single specific site. The term “conjugative transposon” was first used by when characterizing the Tn916 element from E. faecalis.

Targeting MGEs to Combat Antibiotic Resistance

15The ability of bacteria to adapt to all currently available antibiotics has led to an acute need for new, more effective antibiotics or the development of alternative therapeutic strategies. MGEs, especially those containing resistance plasmids, transposons, and integrons, play a crucial role in the accumulation and dissemination of ARGs in both the clinical and environmental sectors. Consequently, there is a strong argument for considering that one potential strategy to control AMR is through the elimination of these MGEs. In the field of medicine, the concept of “curing” refers to various clinical techniques applied to repair a defective system. In terms of AMR, “curing” is predominantly used to describe the process of removing ARGs from bacterial populations, and compounds used for this purpose are called “curing agents.” Considering that most ARGs and virulence factors are located on plasmids, the term “curing” has been associated with the removal of plasmids since 1971. Over the past half-century, several studies have focused on testing antibacterial compounds, such as detergents, biocides, intercalary agents, and nanoparticles (Table 1), bacteriophage- and microbiota-based therapies, or the CRISPR system for curing resistance plasmids.

Chemical Strategies for Removing MGEs

16Chemical agents used for the elimination of resistance elements in bacteria act through several mechanisms, including replication blockage, DNA breaks, or inhibition of conjugation (Tables 1, 2). The effectiveness of the agent varies depending on the bacterial strain, presence of plasmids, and growth conditions.

17Detergents have been used to remove resistance plasmids since 1972. Sodium dodecyl sulfate (SDS) has shown excellent efficiency in removing resistance plasmids in both Gram-positive (e.g., the penicillin resistance plasmid from S. aureus) and Gram-negative (e.g., E. coli and P. aeruginosa) bacteria. However, high concentrations of SDS are required, which result in gastrointestinal side effects and thus prohibit the use of SDS in humans and animals. Another class of compounds used to remove resistance plasmids are the intercalating agents, such as ethidium bromide, acridine-orange, and acriflavine. Elimination of resistance plasmids by ethidium bromide has been demonstrated in Gram-positive (Lactobacillus acidophilus) and Gram-negative (E. coli, Enterobacter aerogenes) bacteria, as well as in actinomycetes (Streptomycetes). Acridine-orange and acriflavine have successfully cured resistance plasmids in E. coli, Salmonella spp. and Shigella spp., Lactobacillus spp., Oenococcus oeni, and S. aureus. However, the use of intercalating agents is associated with the risk of mutagenic effects. Furthermore, intercalating agents appear to be inefficient in eliminating large plasmids, such as those found in Rhizobium spp. and Agrobacterium spp.. Biocides such as triclosan (irgasan) or fusidic acid have been used since 1998 for the successful removal of resistance plasmids in Gram-negative (E. coli) and Gram-positive (methicillin-resistant S. aureus) bacteria.

18Recently, nanoparticles have been proposed as potential tools to combat bacterial resistance. An advantage of using nanoparticles is that they simultaneously target multiple structures, decreasing the risk of selecting/acquiring resistance to them. Nanoparticles exert their antibacterial effects through multiple mechanisms, including destruction of the bacterial membrane with elimination of cytoplasmic components, inactivation of DNA or protein binding, and release of reactive oxygen species. Blocking the function of cellular components leads to oxidative stress, electrolyte imbalance, enzyme inhibition, and finally, cell death. Due to their effects on DNA integrity (double-strand breaks, deaminations, alkylating agent formation, and inhibition of DNA repair enzymes), different nanoparticles might also be regarded as MGE curing agents. Another advantage of using nanoparticles is that their antibacterial action can be maintained for an extended period of time with no loss in stability. Platinum and copper nanoparticles are instrumental in the elimination of resistance plasmids as they interact with the supercoiled plasmid DNA or with topoisomerases involved in replication, transcription, and recombination processes, ultimately leading to elimination of the plasmids. Copper nanoparticles have also been used in plasmid DNA degradation experiments as well as for blocking plasmid conjugation. Despite the potential for metal nanoparticles to be used as weapons against AMR, bacteria are capable of developing resistance to the nanoparticles themselves, probably facilitated by the global use of metals in fields such as agriculture, animal feed supplements, and disinfectant production. Bacterial resistance to silver, copper, and zinc nanoparticles has been highlighted in both Gram-negative and Gram-positive bacteria isolated from inert surfaces, soil, or the intestinal contents of animals fed with zinc and copper supplements. Genes conferring resistance to metals are usually located on plasmids, posing a significant risk of very rapid dissemination through HGT. Furthermore, the co-existence of antibiotic resistance and metal resistance genes within the same MGE is a possible mechanism for selecting antibiotic resistance. Another type of nanoparticle, the organic nanoparticles such as chitosan nanoparticles, demonstrate resistance curing activity by affecting the integrity of plasmid DNA and the conjugation capacity.

19Conjugation is involved in the dissemination of plasmids and other MGEs such as conjugative transposons and ICE. Since most MGEs use the same proteins for their transfer, HGT could be blocked by conjugation inhibitors (COINs) (;; Table 1). Many experiments have demonstrated that intercalating agents, heterocyclic compounds, acridine dyes, quinolones, and unsaturated fatty acids such as linoleic and linolenic acid can act as COINs. A possible target of COINs is relaxase, the most critical enzyme in the conjugation process as it cuts the plasmid at the oriT origin. Inhibiting conjugation by targeting relaxase has been demonstrated for bisphosphonates (etidronate, clodronate) and for specifically designed antibodies. Another potential target of COINs is to limit or block the site-specific recombinase enzymes that have a central role in the transposition process. However, some COINs are unable to translocate the bacterial cell membrane, hence research has been directed toward the discovery of new classes of permeable compounds.

20Chemical agents have been successfully used to remove resistance plasmids, but use of these compounds to limit antibiotic resistance in humans is problematic. As stated previously, high concentrations of SDS are required to remove resistance plasmids and this results in gastrointestinal side effects such as colitis; consequently, SDS use is banned in humans and animals. Studies have demonstrated that intercalating agents are effective in eliminating resistance plasmids, but the risk of mutagenic effects must be considered. Nanoparticles are another weapon against bacterial resistance, but the main impediment to their use in humans is the lack of information regarding their safety and how they affect the biological integrity of organisms, particularly in terms of producing toxicological, cytotoxic, and genotoxic effects. Nanoparticles are predominantly used in doses below the threshold concentrations; thus, they are not considered harmful to the body. However, bioaccumulation of nanoparticles in the body following long-term exposure is well known. Therefore, further research on long-term nanoparticle toxicity and carcinogenesis is needed. Quinolones inhibit bacterial DNA replication by interfering with DNA-gyrase activity, and numerous studies have highlighted the plasmid-curing effect of quinolones in E. coli in vitro and in vivo assays. Despite these results, the use of quinolones to eliminate plasmids containing ARGs may lead to a fitness advantage in plasmid-containing cells and would therefore select for plasmid maintenance. Phenothiazines, such as chlorpromazine, also have plasmid-curing activity in E. coli and methicillin-resistant S. aureus. Although the role of these chemical agents has been demonstrated in vitro, further studies are needed to clarify the efficacy of these compounds in vivo. In the case of chlorpromazine, the concentration required in the intestine to remove resistance plasmids is considerable. For this reason, it is necessary to develop strategies that allow targeted delivery of these chemical agents and avoid oral administration in order to increase their efficiency and reduce the risk of toxicity.

Bacteriophages

21Bacteriophages are viral parasites capable of infecting bacteria by recognizing surface receptors, injecting their genetic material into the host, and replicating using the host cellular machinery. Phages exert ecological and genetic effects on bacteria at the population level, and these effects can impact plasmid stability. This is due to epistatic interactions between the cost of chromosomal phage-resistant mutations and the cost of maintaining plasmids. Although phage-mediated transfer of ARGs between bacteria has been demonstrated for numerous bacterial species, the transduction occurs at a low rate (between 10–6 and 10–9 transductants/pfu). One exception is methicillin-resistant S. aureus that contains a category of MGEs called phage-inducible chromosomal islands (PICIs), which are associated with the highest transduction frequency (10–1 transductants/pfu). Phages may enhance the persistence of ARGs as an adaptation strategy to restrictive environmental conditions, e.g., wastewater aggressively treated using UV, temperature, or pH. However, genetically modified phages could be used to increase antibiotic susceptibility of resistant strains. The alarming increase in resistance has also led to the revival of phage therapy in order to sensitize resistant bacteria by eliminating resistance and virulence factors. showed that the PRD1 phage determined the loss of RP4 and RN3 resistance plasmids from strains of E. coli and Salmonella spp. and inhibited the conjugation ability of the remaining resistant bacteria. Another study demonstrated that the M13KE filamentous phage could block plasmid conjugation by interacting with the conjugative F pilus in E. coli. Furthermore, addition of the M13 phage g3p minor protein results in complete inhibition of conjugation, suggesting this protein has an essential role in the process. eliminated the pQBR103 megaplasmid in P. fluorescens using the SBW252 lytic phage. Recently, revealed that the OMKO1 phage isolated from P. aeruginosa could sensitize antibiotic-resistant strains to erythromycin, ceftazidime, tetracycline, and ciprofloxacin. Together, these studies demonstrate the possibility of using phages to reduce the prevalence of resistance plasmids in bacterial populations as well as to block plasmid conjugation. In addition, phages can be successfully used to increase the sensitivity of bacterial strains to antibiotics.

22Seemingly successful experimental trials using phages to treat pediatric dysentery, cholera and skin infections, and bubonic plague sparked interest in phage therapy both in Europe and the United States. However, attempts to repeat these trials and achieve positive results failed; this was due to an incomplete understanding of phage biology, and because of the large-scale development of a wide range of antibiotics that could be used to treat these infections. Experimental data obtained from the use of phage therapy in animals, as well as data from observational studies conducted in humans, were not followed by clinical studies to confirm the therapeutic value of phages. However, in recent years, the abusive use of broad-spectrum antibiotics, as well as the rapid evolution and dissemination of resistant bacteria, has stimulated research into phage therapy, and data from promising clinical trials have been published. have used phagotherapy in a patient with necrotic pancreatitis caused by a MDR strain of A. baumannii. Other studies have obtained favorable results for the phagotherapy of an aortic graft infection with P. aeruginosa, pneumonia caused by a MDR strain of P. aeruginosa in a cystic fibrosis patient, a Mycobacterium abscessus infection in a patient with cystic fibrosis, and periprosthetic, musculoskeletal, and lung infections. Contrary to these studies, there are reports of the inefficiency of phages in treating bacterial infections, which suggests that the clinical use of phages requires standardization. One of the greatest challenges in phage therapy is the selection of bacterial strains that are resistant to phage action. Further studies are required to clearly understand phage biology and elucidate the mechanisms leading to the emergence of phage resistance.

Incompatibility-Based Plasmid Curing and Toxin/Antitoxin Systems

23Plasmid incompatibility is generally defined as the inability of two co-resident plasmids to be stably inherited in the absence of outside selection. Thus, if the introduction of a second plasmid destabilizes transmission of the first plasmid, the two plasmids are incompatible. This occurs because the two plasmids share the same replication and partitioning mechanisms. Consequently, under the influence of selective pressure, the resident plasmid can be eliminated. Elimination of plasmids based on incompatibility has historically been used to elucidate the mechanisms involved in elimination, and to study the interactions between the plasmid and the host. One of the main disadvantages of incompatibility-based plasmid curing methods is the need for repeated cloning and detailed knowledge of the target plasmid. Also a significant problem in the construction of interference plasmids is the requirement to know the replication and partition control region before curing, as well as the need to include additional plasmid genes. This incompatibility-based strategy has been employed in a variety of bacteria. In L. acidophilus, L. plantarum, and L. pentosus it was used to eliminate approximately 2.3-kb resident plasmids. used plasmid incompatibility to study the role of plasmids in the pathogenesis of Yersinia pestis. The technique has also been used to remove strains of Bacillus anthracis carrying high pathogenicity plasmids, thus allowing observation of their role in capsule formation and toxin production. constructed a plasmid incompatibility system called pCURE to eliminate F-like plasmids and IncP-1α from E. coli. This system comprises elements of repression (transcriptional repressor, antisense RNA), the origin of replication to compete for essential steps, as well as an antitoxin repressor to control the toxin/antitoxin system. Toxin/antitoxin systems, also known as post-segregational cell killing or addiction systems, are components of natural plasmids that ensure their persistence in bacterial populations by blocking the growth of daughter cells that do not inherit the plasmid. These systems consist of a labile antitoxin that quenches the activity of the stable toxin. Blocking antitoxin gene expression upon plasmid loss leads to faster depletion of the antitoxin than the toxin, which de-represses toxin activity, and ultimately results in programmed cell death. Recently, constructed incompatibility plasmids in combination with genes encoding antitoxins and replicons, in order to eliminate the blaIMP–4 and blaCMY–2 genes, in both in vitro and in vivo experimental models. Target plasmids were eliminated in the presence of antibiotics for selecting for the interference plasmid.

24Successful in vitro elimination of plasmids through incompatibility systems suggests that this strategy could be applied in vivo, to both humans and animals. However, in order to achieve this desideratum, in-depth research is necessary to overcome current limitations of the system, such as the need for repeated cloning, detailed characterization of target plasmids, and prior knowledge of replication and segregation control regions. Moreover, the requirement to use antibiotics to select eliminated plasmids may be a significant disadvantage to the method. Another aspect that needs further research is the interaction between the interference and resistance plasmids, including the reduction of antibiotic selection.

Utilization of CRISPR/Cas System to Eliminate MGEs Involved in AMR

25As stated above, strategies to remove MGEs based on chemical compounds, phages, or incompatibility based-curing plasmid systems have many limitations. All previously described strategies require several stages of bacterial growth in the presence of stressor agents, such as high temperature or intercalating agents, which may lead to unwanted mutations. Therefore, novel approaches for the elimination of MGEs involved in AMR have been proposed.

26An attractive alternative strategy for combating bacterial resistance uses the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) system, which was initially described in 1987 by. CRISPR/Cas is an immune defense system in bacteria that is capable of recognizing foreign nucleic acids and destroying them through associated caspases. One of the significant advantages of this system is its high specificity. This is due to the existence of short repetitive sequences in CRISPR loci that are separated from each other by single sequences of 26–72 pairs derived from MGEs such as plasmids or transposons. The CRISPR/Cas mechanism of defense against foreign genetic elements is accomplished in three stages: acquisition, expression, and interference. The acquisition stage comprises the insertion of single sequences (spacers) derived from MGEs into repetitive loci of the host chromosome; these sequences are separated from each other by repetitive sequences. The expression stage involves transcribing the complex of repetitive and spacer sequences into a single RNA transcript that will be further processed by caspases in short CRISPR RNAs. In the final stage, the interference phase, foreign nucleic acids are identified based on complementarity with CRISPR RNAs, and their degradation is executed by caspases. Discrimination between self and non-self is accomplished through sequences from the foreign nucleic acid called protospacers. These sequences are positioned between short DNA sequences (2–6 bp) called protospacer adjacent motifs (PAMs). Cas9 (CRISPR-associated protein 9) will not cleave to a protospacer sequence unless there is a neighboring PAM. CRISPR loci do not contain PAMs, hence direct target recognition is achieved by the CRISPR system without the risk of degrading its own nucleic acid (; Figure 3). The CRISPR system is classified into six main types and 33 subtypes. Each type has several structural and functional characteristics, but the most distinctive feature is the cas genes and proteins they encode, which play an essential role in recognizing and degrading invading nucleic acids. The number of cas genes ranges from 4 to 20, and the diversity of the corresponding Cas proteins form an ensemble of properties that are essential to the CRISPR immune mechanism.

27The idea that the CRISPR system could acquire new repetitive nucleic acid sequences of extrachromosomal origin, mainly from phages and plasmids, significantly increased interest in using the system to limit HGT by blocking plasmid conjugation. Subsequently, there have been numerous studies on this topic. The first study of this type was conducted by. The authors attempted to use the CRISPR system interference to block the conjugation of plasmids in S. epidermidis. S. epidermidis strains contain a CRISPR locus containing a homolog spc1 spacer with a region encoding the nickase gene found in conjugative plasmids from this strains. Silent mutations were introduced into the target gene of the pG0400 conjugate plasmid, generating a mutant plasmid (pG0). Both wild-type and mutant plasmids were tested for conjugation ability. In the control strain, which lacked the CRISPR locus and spc1 complementary to the nickase gene, the conjugation frequency was similar for both plasmids. In the strain harboring the CRISPR locus, only the mutated plasmid with the modified sequence was transferred by conjugation. This demonstrated that the CRISPR system could block plasmid conjugation in a site-specific manner. Furthermore, based on the complementarity between the spc1 spacer and the nickase gene region, the authors showed that CRISPR interference could block plasmid transformation. showed that the CRISPR system could edit the genome of E. coli. An A to C transversion was introduced in the rpsL gene and a pCRISPR:rpsL plasmid harboring a spacer that would guide dual-RNA:Cas9 cleavage of the wild-type rpsL gene was constructed. Following incubation of the strain of interest with the plasmid, deletion of the rpsL gene was observed. Removal of ARGs was also demonstrated by, using a variant of the CRISPR system encountered in S. pyogenes. The authors built plasmids in which they introduced the CRISPR elements as well as a copy of the blaSHV–18 and blaNDM–1 target genes, conferring resistance to extended-spectrum beta-lactam antibiotics. Elimination of blaSHV–18 and blaNDM–1 plasmids was achieved by packaging the CRISPR elements into a bacteriophage. Following treatment of clinical isolates of E. coli bearing the target plasmids with the constructed phage, a significant reduction in viable bacterial cells was observed. Removal of kanamycin resistance genes through the CRISPR system has been demonstrated by for strains of S. aureus.

28introduced the CRISPR elements (cas genes, and spacer sequences targeting the blaNDM-1 and blaCTX-M-15 genes) into a lysogenic phage, and following lysogenization of the resistant bacteria with the constructed phage, elimination of resistance plasmids was observed. The CRISPR system had exhibited the ability to not only remove resistance plasmids, but also to block their HGT. designed a CRISPR plasmid capable of recognizing the blaTEM and blaSHV genes from strains of E. coli producing extended-spectrum β-lactamases. Following transformation of bacterial cells with the CRISPR plasmid, elimination of plasmid-encoding beta-lactamase production was observed, demonstrating the action of caspase at the level of the blaTEM and blaSHV target regions. Furthermore, after elimination of the resistance plasmid, the bacterial strains became sensitive to a series of other antibiotics to which they have previously shown resistance. constructed a pMBLcas9 plasmid expressing Cas9, used to clone target single-guide RNAs (sgRNAs) for plasmid curing. The recombinant plasmid pMBLcas9-sgRNA was transferred by conjugation into two clinical isolates of E. coli. In this study, four native plasmids in isolate 14EC033 and two native plasmids in isolate 14EC007 were successfully eliminated in a stepwise manner using pMBLcas9. In addition, two native plasmids in 14EC007 were simultaneously eliminated by tandemly cloning multiple sgRNA in pMBLcas9, sensitizing isolate 14EC007 to polymyxin and carbenicillin. In Zymomonas mobilis strain ZM4 the resistance plasmids pZZM402 and pZZM403 were eliminated by targeting the replicase-encoding gene which, once inactivated, impairs plasmid replication and leads to subsequent elimination. The CRISPR system was also used to target some conserved regions within the ColE1 replicons encountered in 91% of the plasmids found in the databases. constructed a vector in which they introduced all required CRISPR elements as well as two complementary RNA sequences with the conserved regions that guide the cascade nine nuclease to introduce double-strand breaks. This induced elimination of resistance plasmids in E. coli and other bacteria possessing replicons with conserved regions that are targets for the CRISPR system. CRISPR systems have been designed and delivered in E. coli via transformation and conjugation to eliminate the plasmid-borne mcr-1 gene. Efficient editing of a target locus using a CRISPR-based system was achieved in S. aureus, B. subtilis, E. faecalis, and E. coli. In summary, this array of studies conducted on various bacterial strains demonstrates the utility of the CRISPR system to eliminate resistance plasmids, as well as blocking HGT of the plasmids. The CRISPR system can also be used for antibiotic sensitization of resistant strains.

29Many protocols for plasmid curing/ARG elimination using CRISPR have been proposed (Table 3). However, there are some limitations of this strategy. These limitations include: a known target plasmid replication mechanism is required,; there is a risk of chromosomal ARG acquisition in the interfering plasmid; and the majority of the studies demonstrating the ability of the CRISPR system to eliminate resistance plasmids, as well as to block the dissemination of ARGs by HTG, were performed in vitro. The efficiency of the CRISPR system to eliminate ARGs has been demonstrated in vivo in different mammalian models. revealed that the E. faecalis CRISPR system could block dissemination of resistance plasmids in the mouse gut. However, it remains to be established how much can be extrapolated from these studies to other mammalian organisms. Successful oral administration of phages for targeting bacteria in the intestinal tract has led to the proposal that phages could be used as a vehicle for delivering the CRISPR system into intestinal microbiota to eliminate ARGs. However, this would require a collection of phages specially designed to target ARGs, the optimal concentration would need to be established, and knowledge of several barriers that occur in vivo would be required, such as inactivation of bacteriophages by gastric acid, and neutralization of phages by the spleen and the immune system.

Conclusion

30The global increase in antibiotic resistance is a significant challenge in the fields of medicine and microbial ecology. Rapid development of effective strategies to reduce and control bacterial resistance is required. MGEs have a pivotal role in the acquisition and transmission of ARGs in clinical and environmental sectors, and one approach to control resistance is through elimination of these MGEs. Different chemical (biocides, nanoparticles, antibodies) and biological (engineered phages, commensal microbiota) strategies have been developed, with most of the strategies being directed toward curing the resistance plasmids or inhibiting the conjugation process. However, despite the potential array of approaches directed toward elimination of MGEs, these strategies need refining to overcome the challenges identified in this literature survey. These challenges include the cost-efficiency ratio, the narrow bacterial host spectrum, resistance to phages or chemical agents, the need for a known target plasmid replication mechanism, the risk of chromosomal ARG acquisition in the interfering plasmid (CRISPR technology), and the inability to remove big plasmids. Future work should focus on tackling these challenges to develop a successful strategy to combat antibiotic resistance.

Author Contributions

31MC conceived and corrected the manuscript. MC, CB, LP, and CV contributed to the literature survey and revised the manuscript. CV drafted the manuscript. LP designed the figures.

Conflict of Interest

32The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 244

1.
Abedon S. T. Kuhl S. J. Blasdel B. G. Kutter E. M. (2011 ). Phage treatment of human infections. Bacteriophage 1 66–85.
Not in our library10.4161/bact.1.2.15845
2.
Adetosoye A. I. Rotilu I. O. (1985 ). Infectious drug resistance and antibiotic resistance curing in Salmonella and Shigella isolates from cases of diarrhoea. Revue d’elevage Med. Vet. Pays Trop. 38 433–437.
Not in our library
3.
Characterization of copper-resistant bacteria and bacterial communities from copper-polluted agricultural soils of central Chile · 2012
No notice
4.
Horizontal gene exchange in environmental microbiota · 2011
Not checked
5.
Antonoglou O. Lafazanis K. Mourdikoudis S. Vourlias G. Lialiaris T. Pantazaki A. (2019 ). Biological relevance of CuFeO2 nanoparticles: antibacterial and anti-inflammatory activity, genotoxicity. DNA and protein interactions. Mater. Sci. Eng. C Mater. Biol. Appl. 99 264–274.
Not in our library10.1016/j.msec.2019.01.112
6.
Azam A. H. Tanji Y. (2019 ). Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy. Appl. Microbiol. Biotechnol. 103 2121–2131.
Not in our library10.1007/s00253-019-09629-x
7.
Babakhani S. Oloomi M. (2018 ). Transposons: the agents of antibiotic resistance in bacteria. J. Basic Microbiol. 58 905–917.
Not in our library10.1002/jobm.201800204
8.
Baquero F. Coque T. M. de la Cruz F. (2011 ). Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob. Agents Chemother. 55 3649–3660.
Not in our library10.1128/aac.00013-11
9.
Bavya M. C. Vimal Rohan K. Gaurav G. B. Srivasatava R. (2019 ). Synergistic treatment strategies to combat resistant bacterial infections using Schiff base modified nanoparticulate - hydrogel system. Mater. Sci. Eng. C Mater. Biol. Appl. 95 226–235.
Not in our library10.1016/j.msec.2018.10.080
10.
Plasmid-Encoded Transferable mecB -Mediated Methicillin Resistance in Staphylococcus aureus · 2018
No notice
11.
Bedzyk L. A. Shoemaker N. B. Young K. E. Salyers A. A. (1992 ). Insertion and excision of Bacteroides conjugative chromosomal elements. J. Bacteriol. 174 166–172.
Not in our library10.1128/jb.174.1.166-172.1992
12.
Belaynehe K. M. Shin S. W. Yoo H. S. (2018 ). Interrelationship between tetracycline resistance determinants, phylogenetic group affiliation and carriage of class 1 integrons in commensal Escherichia coli isolates from cattle farms. BMC Vet. Res. 14:340.
Not in our library10.1186/s12917-018-1661-3
13.
Bennett P. M. (1999 ). Integrons and gene cassettes: a genetic construction kit for bacteria. J. Antimicrob. Chemother. 43 1–4.
Not in our library
14.
Bennett P. M. (2004 ). “Genome plasticity Methods,” in Molecular Biology Vol 266 Genomics, Proteomics and Clinical Bacteriology, eds Woodford N. Johnson A. (Totowa: Human Press Inc), 71–113.
Not in our library
15.
Bennett P. M. (2008 ). Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br. J. Pharmacol. 153(Suppl. 1), S347–S357.
Not in our library10.1038/sj.bjp.0707607
16.
Berglund B. Hoang N. T. B. Tarnberg M. Le N. K. Svartstrom O. Khu D. T. K. (2018 ). Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant Klebsiella pneumoniae from Vietnam. Int. J. Antimicrob. Agents 51 789–793.
Not in our library10.1016/j.ijantimicag.2017.11.012
17.
Bikard D. Euler C. W. Jiang W. Nussenzweig P. M. Goldberg G. W. Duportet X. (2014 ). Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat. Biotechnol. 32 1146–1150.
Not in our library10.1038/nbt.3043
18.
Bocharova Y. Savinova T. Shagin D. A. Shelenkov A. A. Mayanskiy N. A. Chebotar I. V. (2019 ). Inactivation of the oprD porin gene by a novel insertion sequence ISPa195 associated with large deletion in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate. J. Glob. Antimicrob. Resistance 17 309–311.
Not in our library10.1016/j.jgar.2019.01.016
19.
Bolotin A. Quinquis B. Sorokin A. Ehrlich S. D. (2005 ). Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151(Pt 8), 2551–2561.
Not in our library10.1099/mic.0.28048-0
20.
Bouanchaud D. H. Chabbert Y. A. (1971 ). The problems of drug-resistant pathogenic bacteria. Practical effectiveness of agents curing R factors and plasmids. Ann. N. Y. Acad. Sci. 182 305–311.
Not in our library10.1111/j.1749-6632.1971.tb30666.x
21.
Bozkir A. Saka O. M. (2004 ). Chitosan-DNA nanoparticles: effect on DNA integrity, bacterial transformation and transfection efficiency. J. Drug Target. 12 281–288.
Not in our library10.1080/10611860410001714162
22.
Bringel F. Frey L. Hubert J. C. (1989 ). Characterization, cloning, curing, and distribution in lactic acid bacteria of pLP1, a plasmid from Lactobacillus plantarum CCM 1904 and its use in shuttle vector construction. Plasmid 22 193–202.
Not in our library10.1016/0147-619x(89)90002-4
23.
Brochet M. Da Cunha V. Couve E. Rusniok C. Trieu-Cuot P. Glaser P. (2009 ). Atypical association of DDE transposition with conjugation specifies a new family of mobile elements. Mol. Microbiol. 71 948–959.
Not in our library10.1111/j.1365-2958.2008.06579.x
24.
Buckling A. Rainey P. B. (2002 ). Antagonistic coevolution between a bacterium and a bacteriophage. Proc. Biol. Sci. 269 931–936.
Not in our library10.1098/rspb.2001.1945
25.
Strategies to combat antimicrobial resistance: anti-plasmid and plasmid curing · 2018
No notice
26.
Burrus V. (2017 ). Mechanisms of stabilization of integrative and conjugative elements. Curr. Opin. Microbiol. 38 44–50.
Not in our library10.1016/j.mib.2017.03.014
27.
Burrus V. Pavlovic G. Decaris B. Guedon G. (2002 ). Conjugative transposons: the tip of the iceberg. Mol. Microbiol. 46 601–610.
Not in our library10.1046/j.1365-2958.2002.03191.x
28.
Burrus V. Waldor M. K. (2004 ). Shaping bacterial genomes with integrative and conjugative elements. Res. Microbiol. 155 376–386.
Not in our library10.1016/j.resmic.2004.01.012
29.
Calero-Caceres W. Muniesa M. (2016 ). Persistence of naturally occurring antibiotic resistance genes in the bacteria and bacteriophage fractions of wastewater. Water Res. 95 11–18.
Not in our library10.1016/j.watres.2016.03.006
30.
Cambray G. Guerout A. M. Mazel D. (2010 ). Integrons. Ann. Rev. Genet. 44 141–166.
Not in our library10.1146/annurev-genet-102209-163504
31.
Cameranesi M. M. Moran-Barrio J. Limansky A. S. Repizo G. D. Viale A. M. (2018 ). Site-Specific Recombination at XerC/D Sites Mediates the Formation and Resolution of Plasmid Co-integrates Carrying a blaOXA-58- and TnaphA6-Resistance Module in Acinetobacter baumannii. Front. Microbiol. 9:66.
Not in our library10.3389/fmicb.2018.00066
32.
Cannatelli A. Giani T. D’Andrea M. M. Di Pilato V. Arena F. Conte V. (2014 ). MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob. Agents Chemother. 58 5696–5703.
Not in our library10.1128/aac.03110-14
33.
Cao Q. H. Shao H. H. Qiu H. Li T. Zhang Y. Z. Tan X. M. (2017 ). Using the CRISPR/Cas9 system to eliminate native plasmids of Zymomonas mobilis ZM4. Biosci. Biotechnol. Biochem. 81 453–459.
Not in our library10.1080/09168451.2016.1189312
34.
Carattoli A. (2013 ). Plasmids and the spread of resistance. IJMM 303 298–304.
Not in our library10.1016/j.ijmm.2013.02.001
35.
Cason J. S. Jackson D. M. Lowbury E. J. Ricketts C. R. (1966 ). Antiseptic and aseptic prophylaxis for burns: use of silver nitrate and of isolators. Br. Med. J. 2 1288–1294.
Not in our library10.1136/bmj.2.5525.1288
36.
Castanheira M. Gales A. Walsh T. R. Campana E. H. Tolema M. A. (2007 ). “Association of blaSPM-1 with the transposon Tn4371,” in Proceedings od the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 17-20 September 2007, Chicago, IL.
Not in our library
37.
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa · 2016
No notice
38.
Phage treatment of an aortic graft infected with Pseudomonas aeruginosa · 2018
No notice
39.
Chassy B. M. Gibson E. M. Guiffrida A. (1978 ). Evidence for plasmid-associated lactose metabolism inLactobacillus casei subsp.casei. Curr. Microbiol. 1 141–144.
Not in our library10.1007/bf02601666
40.
Chatterjee A. K. Chakraborty R. Basu T. (2014 ). Mechanism of antibacterial activity of copper nanoparticles. Nanotechnology 25:135101.
Not in our library10.1088/0957-4484/25/13/135101
41.
Cheow W. S. Hadinoto K. (2014 ). Antibiotic polymeric nanoparticles for biofilm-associated infection therapy. Methods Mol. Biol. 1147 227–238.
Not in our library10.1007/978-1-4939-0467-9_16
42.
Citorik R. J. Mimee M. Lu T. K. (2014 ). Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat. Biotechnol. 32 1141–1145.
Not in our library10.1038/nbt.3011
43.
Cochetti I. Tili E. Mingoia M. Varaldo P. E. Montanari M. P. (2008 ). erm(B)-carrying elements in tetracycline-resistant pneumococci and correspondence between Tn1545 and Tn6003. Antimicrob. Agents Chemother. 52 1285–1290.
Not in our library10.1128/aac.01457-07
44.
Corbellino M. Kieffer N. Kutateladze M. Balarjishvili N. Leshkasheli L. Askilashvili L. (2019 ). Eradication of a multi-drug resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom-made, lytic bacteriophage preparation. Clin. Infect. Dis. 70 1998–2001.
Not in our library10.1093/cid/ciz782
45.
Costa S. S. Ntokou E. Martins A. Viveiros M. Pournaras S. Couto I. (2010 ). Identification of the plasmid-encoded qacA efflux pump gene in meticillin-resistant Staphylococcus aureus (MRSA) strain HPV107, a representative of the MRSA Iberian clone. Int. J. Antimicrob. Agents 36 557–561.
Not in our library10.1016/j.ijantimicag.2010.08.006
46.
Courtright J. B. Turowski D. A. Sonstein S. A. (1988 ). Alteration of bacterial DNA structure, gene expression, and plasmid encoded antibiotic resistance following exposure to enoxacin. J. Antimicrob. Chemother. 21(Suppl. B), 1–18.
Not in our library10.1093/jac/21.suppl_b.1
47.
Crameri R. Davies J. E. Hutter R. (1986 ). Plasmid curing and generation of mutations induced with ethidium bromide in streptomycetes. J. Gen. Microbiol. 132 819–824.
Not in our library10.1099/00221287-132-3-819
48.
Crawley A. B. Henriksen E. D. Stout E. Brandt K. Barrangou R. (2018 ). Characterizing the activity of abundant, diverse and active CRISPR-Cas systems in lactobacilli. Sci. Rep. 8:11544.
Not in our library10.1038/s41598-018-29746-3
49.
D’Costa V. M. McGrann K. M. Hughes D. W. Wright G. D. (2006 ). Sampling the antibiotic resistome. Science 311 374–377.
Not in our library10.1126/science.1120800
50.
de la Cruz F. Frost L. S. Meyer R. J. Zechner E. L. (2010 ). Conjugative DNA metabolism in Gram-negative bacteria. FEMS Microbiol. Rev. 34 18–40.
Not in our library10.1111/j.1574-6976.2009.00195.x
51.
Dedrick R. M. Guerrero-Bustamante C. A. Garlena R. A. Russell D. A. Ford K. Harris K. (2019 ). Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat. Med. 25 730–733.
Not in our library10.1038/s41591-019-0437-z
52.
Delavat F. Miyazaki R. Carraro N. Pradervand N. van der Meer J. R. (2017 ). The hidden life of integrative and conjugative elements. FEMS Microbiol. Rev. 41 512–537.
Not in our library10.1093/femsre/fux008
53.
Diep B. A. Gill S. R. Chang R. F. Phan T. H. Chen J. H. Davidson M. G. (2006 ). Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367 731–739.
Not in our library10.1016/s0140-6736(06)68231-7
54.
Dobrindt U. Hochhut B. Hentschel U. Hacker J. (2004 ). Genomic islands in pathogenic and environmental microorganisms. Nat. Rev. Microbiol. 2 414–424.
Not in our library10.1038/nrmicro884
55.
Dong H. Xiang H. Mu D. Wang D. Wang T. (2019 ). Exploiting a conjugative CRISPR/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli. Int. J. Antimicrob. Agents 53 1–8.
Not in our library10.1016/j.ijantimicag.2018.09.017
56.
Dow K. H. (1990 ). The enduring seasons in survival. Oncol. Nurs. Forum 17 511–516.
Not in our library
57.
Dupont C. L. Grass G. Rensing C. (2011 ). Copper toxicity and the origin of bacterial resistance–new insights and applications. Metallomics 3 1109–1118.
Not in our library10.1039/c1mt00107h
58.
Faghri J. Nouri S. Jalalifar S. Zalipoor M. Halaji M. (2018 ). Investigation of antimicrobial susceptibility, class I and II integrons among Pseudomonas aeruginosa isolates from hospitalized patients in Isfahan. Iran. BMC Res. Notes 11:806.
Not in our library10.1186/s13104-018-3901-9
59.
Fennewald M. A. Capobianco J. (1984 ). Isolation and analysis of inhibitors of transposon Tn3 site-specific recombination. J. Bacteriol. 159 404–406.
Not in our library10.1128/jb.159.1.404-406.1984
60.
Fernandez-Lopez R. Garcillan-Barcia M. P. Revilla C. Lazaro M. Vielva L. de la Cruz F. (2006 ). Dynamics of the IncW genetic backbone imply general trends in conjugative plasmid evolution. FEMS Microbiol. Rev. 30 942–966.
Not in our library10.1111/j.1574-6976.2006.00042.x
61.
Fernandez-Lopez R. Machon C. Longshaw C. M. Martin S. Molin S. Zechner E. L. (2005 ). Unsaturated fatty acids are inhibitors of bacterial conjugation. Microbiology 151(Pt 11), 3517–3526.
Not in our library10.1099/mic.0.28216-0
62.
Fessler A. Kadlec K. Wang Y. Zhang W. J. Wu C. Shen J. (2018 ). Small antimicrobial resistance plasmids in livestock-associated methicillin-resistant Staphylococcus aureus CC398. Front. Microbiol. 9:2063.
Not in our library10.3389/fmicb.2018.02063
63.
Fonseca E. L. Marin M. A. Encinas F. Vicente A. C. (2015 ). Full characterization of the integrative and conjugative element carrying the metallo-beta-lactamase bla SPM-1 and bicyclomycin bcr1 resistance genes found in the pandemic Pseudomonas aeruginosa clone SP/ST277. J. Antimicrob. Chemother. 70 2547–2550.
Not in our library10.1093/jac/dkv152
64.
Franke A. E. Clewell D. B. (1981 ). Evidence for a chromosome-borne resistance transposon (Tn916) in Streptococcus faecalis that is capable of “conjugal” transfer in the absence of a conjugative plasmid. J. Bacteriol. 145 494–502.
Not in our library10.1128/jb.145.1.494-502.1981
65.
Friedman N. D. Temkin E. Carmeli Y. (2016 ). The negative impact of antibiotic resistance. Clin. Microbiol. Infect. 22 416–422.
Not in our library10.1016/j.cmi.2015.12.002
66.
Frost L. S. Leplae R. Summers A. O. Toussaint A. (2005 ). Mobile genetic elements: the agents of open source evolution. Nat. Rev. Microbiol. 3 722–732.
Not in our library10.1038/nrmicro1235
67.
Fu K. P. Grace M. E. Hsiao C. L. Hung P. P. (1988 ). Elimination of antibiotic-resistant plasmids by quinolone antibiotics. Chemotherapy 34 415–418.
Not in our library10.1159/000238601
68.
Gao P. Nie X. Zou M. Shi Y. Cheng G. (2011 ). Recent advances in materials for extended-release antibiotic delivery system. J. Antibiot. 64 625–634.
Not in our library10.1038/ja.2011.58
69.
Garcillan-Barcia M. P. de la Cruz F. (2008 ). Why is entry exclusion an essential feature of conjugative plasmids? Plasmid 60 1–18.
Not in our library10.1016/j.plasmid.2008.03.002
70.
Garcillan-Barcia M. P. Jurado P. Gonzalez-Perez B. Moncalian G. Fernandez L. A. de la Cruz F. (2007 ). Conjugative transfer can be inhibited by blocking relaxase activity within recipient cells with intrabodies. Mol. Microbiol. 63 404–416.
Not in our library10.1111/j.1365-2958.2006.05523.x
71.
Genilloud O. Blazquez J. Mazodier P. Moreno F. (1988 ). A clinical isolate of transposon Tn5 expressing streptomycin resistance in Escherichia coli. J. Bacteriol. 170 1275–1278.
Not in our library10.1128/jb.170.3.1275-1278.1988
72.
Giedraitiene A. Vitkauskiene A. Naginiene R. Pavilonis A. (2011 ). Antibiotic resistance mechanisms of clinically important bacteria. Medicina 47 137–146.
Not in our library
73.
Giordano C. Barnini S. Tsioutis C. Chlebowicz M. A. Scoulica E. V. Gikas A. (2018 ). Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on plasmids. Int. J. Antimicrob. Agents 51 260–265.
Not in our library10.1016/j.ijantimicag.2017.10.011
74.
Gonzalez-Candelas F. Francino M. P. (2012 ). “Barriers to horizontal gene transfer: fuzzy and evolvable boundaries Horizontal gene transfer,” in Microorganisms, ed. Francino M. (UnitedKingdom: Caister Academic Press), 47–75.
Not in our library
75.
Grindley N. D. Whiteson K. L. Rice P. A. (2006 ). Mechanisms of site-specific recombination. Ann. Rev. Biochem. 75 567–605.
Not in our library10.1146/annurev.biochem.73.011303.073908
76.
Grundmann H. Aires-de-Sousa M. Boyce J. Tiemersma E. (2006 ). Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368 874–885.
Not in our library10.1016/s0140-6736(06)68853-3
77.
Guglielmini J. Neron B. Abby S. S. Garcillan-Barcia M. P. de la Cruz F. Rocha E. P. (2014 ). Key components of the eight classes of type IV secretion systems involved in bacterial conjugation or protein secretion. Nucleic Acids Res. 42 5715–5727.
Not in our library10.1093/nar/gku194
78.
Guimaraes L. C. Florczak-Wyspianska J. de Jesus L. B. Viana M. V. Silva A. Ramos R. T. (2015 ). Inside the Pan-genome - methods and software overview. Curr. Genomics 16 245–252.
Not in our library10.2174/1389202916666150423002311
79.
Gupta A. Silver S. (1998 ). Silver as a biocide: will resistance become a problem? Nat. Biotechnol. 16:888.
Not in our library10.1038/nbt1098-888
80.
Hacker J. Bender L. Ott M. Wingender J. Lund B. Marre R. (1990 ). Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro and in vivo in various extraintestinal Escherichia coli isolates. Microb. Pathog. 8 213–225.
Not in our library10.1016/0882-4010(90)90048-u
81.
Hacker J. Knapp S. Goebel W. (1983 ). Spontaneous deletions and flanking regions of the chromosomally inherited hemolysin determinant of an Escherichia coli O6 strain. J. Bacteriol. 154 1145–1152.
Not in our library10.1128/jb.154.3.1145-1152.1983
82.
Hahn F. E. Ciak J. (1976 ). Elimination of resistance determinants from R-factor R1 by intercalative compounds. Antimicrob. Agents Chemother. 9 77–80.
Not in our library10.1128/aac.9.1.77
83.
Hale L. Lazos O. Haines A. Thomas C. (2010 ). An efficient stress-free strategy to displace stable bacterial plasmids. Biotechniques 48 223–228.
Not in our library10.2144/000113366
84.
Hamidian M. Ambrose S. J. Hall R. M. (2016 ). A large conjugative Acinetobacter baumannii plasmid carrying the sul2 sulphonamide and strAB streptomycin resistance genes. Plasmid 8 43–50.
Not in our library10.1016/j.plasmid.2016.09.001
85.
Harada S. Ishii Y. Saga T. Tateda K. Yamaguchi K. (2010 ). Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate. Antimicrob. Agents Chemother. 54 3545–3550.
Not in our library10.1128/aac.00111-10
86.
Harrison E. Wood A. J. Dytham C. Pitchford J. W. Truman J. Spiers A. (2015 ). Bacteriophages limit the existence conditions for conjugative plasmids. mBio 6:e00586-15.
Not in our library10.1128/mbio.00586-15
87.
Hasan A. Morshed M. Memic A. Hassan S. Webster T. J. Marei H. E. (2018 ). Nanoparticles in tissue engineering: applications, challenges and prospects. Int. J. Nanomed. 13 5637–5655.
Not in our library10.2147/ijn.s153758
88.
Hayes F. (2003 ). Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest. Science 301 1496–1499.
Not in our library10.1126/science.1088157
89.
Hochhut B. Jahreis K. Lengeler J. W. Schmid K. (1997 ). CTnscr94, a conjugative transposon found in enterobacteria. J. Bacteriol. 179 2097–2102.
Not in our library10.1128/jb.179.7.2097-2102.1997
90.
Holmes A. H. Moore L. S. Sundsfjord A. Steinbakk M. Regmi S. Karkey A. (2016 ). Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387 176–187.
Not in our library10.1016/s0140-6736(15)00473-0
91.
Huang L. Dai T. Xuan Y. Tegos G. P. Hamblin M. R. (2011 ). Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infections. Antimicrob. Agents Chemother. 55 3432–3438.
Not in our library10.1128/aac.01803-10
92.
Hullahalli K. Rodrigues M. Palmer K. L. (2017 ). Exploiting CRISPR-Cas to manipulate Enterococcus faecalis populations. eLife 6:e26664.
Not in our library10.7554/elife.26664
93.
Ilangovan A. Connery S. Waksman G. (2015 ). Structural biology of the Gram-negative bacterial conjugation systems. Trends Microbiol. 23 301–310.
Not in our library10.1016/j.tim.2015.02.012
94.
Irish D. Eltringham I. Teall A. Pickett H. Farelly H. Reith S. (1998 ). Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin. J. Hospital Infect. 39 19–26.
Not in our library10.1016/s0195-6701(98)90239-0
95.
Ishino Y. Shinagawa H. Makino K. Amemura M. Nakata A. (1987 ). Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J. Bacteriol. 169 5429–5433.
Not in our library10.1128/jb.169.12.5429-5433.1987
96.
Jacoby G. A. Strahilevitz J. Hooper D. C. (2014 ). Plasmid-mediated quinolone resistance. Microbiol. Spectr. 2.
Not in our library10.1128/microbiolspec.plas-0006-2013
97.
Jaidane N. Naas T. Mansour W. Radhia B. B. Jerbi S. Boujaafar N. (2018 ). Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii. Int. J. Antimicrob. Agents 51 266–269.
Not in our library10.1016/j.ijantimicag.2017.10.016
98.
Jalasvuori M. Friman V. P. Nieminen A. Bamford J. K. Buckling A. (2011 ). Bacteriophage selection against a plasmid-encoded sex apparatus leads to the loss of antibiotic-resistance plasmids. Biol. Lett. 7 902–905.
Not in our library10.1098/rsbl.2011.0384
99.
Jault P. Leclerc T. Jennes S. Pirnay J. P. Que Y. A. Resch G. (2019 ). Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect. Dis. 19 35–45.
Not in our library10.1016/s1473-3099(18)30482-1
100.
Jiang W. Bikard D. Cox D. Zhang F. Marraffini L. A. (2013 ). RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31 233–239.
Not in our library10.1038/nbt.2508
101.
Dissemination of antibiotic resistance genes from antibiotic producers to pathogens · 2017
No notice
102.
Johnson C. M. Grossman A. D. (2015 ). Integrative and Conjugative Elements (ICEs): what they do and how they work. Ann. Rev. Genet. 49 577–601.
Not in our library10.1146/annurev-genet-112414-055018
103.
Jones M. L. Ganopolsky J. G. Labbe A. Prakash S. (2010 ). A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: preparation and in vitro analysis. Appl. Microbiol. Biotechnol. 87 509–516.
Not in our library10.1007/s00253-010-2490-x
104.
Juhas M. Power P. M. Harding R. M. Ferguson D. J. Dimopoulou I. D. Elamin A. R. (2007 ). Sequence and functional analyses of Haemophilus spp. genomic islands. Genome Biol. 8:R237.
Not in our library10.1186/gb-2007-8-11-r237
105.
Genomic islands: tools of bacterial horizontal gene transfer and evolution · 2009
No notice
106.
Kado C. I. (2014 ). Historical events that spawned the field of plasmid biology. Microbiol. Spectr. 2:10.1128/microbiolspec.PLAS-0019-2013.
Not in our library10.1128/microbiolspec.plas-0019-2013
107.
Kamruzzaman M. Shoma S. Thomas C. M. Partridge S. R. Iredell J. R. (2017 ). Plasmid interference for curing antibiotic resistance plasmids in vivo. PLoS One 12:e0172913.
Not in our library10.1371/journal.pone.0172913
108.
Karthikeyan V. Santosh S. W. (2010 ). Comparing the efficacy of plasmid curing agents in Lactobacillus acidophilus. Benef. Microb. 1 155–158.
Not in our library10.3920/bm2009.0038
109.
Kennedy I. (1981 ). The Unmasking of Medicine. London: Paladin, Granada Publishmg.
Not in our library
110.
Keyhani J. Keyhani E. Attar F. Haddadi A. (2006 ). Sensitivity to detergents and plasmid curing in Enterococcus faecalis. J. Indus. Microbiol. Biotechnol. 33 238–242.
Not in our library10.1007/s10295-005-0261-y
111.
Kim J. S. Cho D. H. Park M. Chung W. J. Shin D. Ko K. S. (2016 ). CRISPR/Cas9-Mediated re-sensitization of antibiotic-resistant Escherichia coli harboring extended-spectrum beta-lactamases. J. Microbiol. Biotechnol. 26 394–401.
Not in our library10.4014/jmb.1508.08080
112.
Klockgether J. Wurdemann D. Reva O. Wiehlmann L. Tummler B. (2007 ). Diversity of the abundant pKLC102/PAGI-2 family of genomic islands in Pseudomonas aeruginosa. J. Bacteriol. 189 2443–2459.
Not in our library10.1128/jb.01688-06
113.
Klumper U. Dechesne A. Riber L. Brandt K. K. Gulay A. Sorensen S. J. (2017 ). Metal stressors consistently modulate bacterial conjugal plasmid uptake potential in a phylogenetically conserved manner. ISME J. 11 152–165.
Not in our library10.1038/ismej.2016.98
114.
Knetsch M. Koole L. (2011 ). New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles. Polymers 3 340–366.
Not in our library
115.
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study · 2010
No notice
116.
Lakshmi V. V. Polasa H. (1991 ). Curing of pBR322 and pBR329 plasmids in Escherichia coli by cis-dichlorodiamine platinum(II) chloride (Cis-DDP). FEMS Microbiol. Lett. 62 281–284.
Not in our library10.1016/0378-1097(91)90171-6
117.
Lakshmi V. V. Sridhar P. Khan B. T. Polasa H. (1988 ). Mixed-ligand complexes of platinum(II) as curing agents for pBR322 and pBR329 (ColE1) plasmids in Escherichia coli. J. Gen. Microbiol. 134 1977–1981.
Not in our library10.1099/00221287-134-7-1977
118.
Landecker H. (2016 ). Antibiotic resistance and the biology of history. Body Soc. 22 19–52.
Not in our library10.1177/1357034x14561341
119.
Lanka E. Wilkins B. M. (1995 ). DNA processing reactions in bacterial conjugation. Ann. Rev. Biochem. 64 141–169.
Not in our library10.1038/sj.emboj.7601806
120.
Lauritsen I. Kim S. H. Porse A. Norholm M. H. H. (2018 ). Standardized cloning and curing of plasmids. Methods Mol. Biol. 1772 469–476.
Not in our library10.1007/978-1-4939-7795-6_28
121.
Lauritsen I. Porse A. Sommer M. O. A. Norholm M. H. H. (2017 ). A versatile one-step CRISPR-Cas9 based approach to plasmid-curing. Microb. Cell Fact. 16:135.
Not in our library10.1186/s12934-017-0748-z
122.
Law N. Logan C. Yung G. Furr C. L. Lehman S. M. Morales S. (2019 ). Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient. Infection 47 665–668.
Not in our library10.1007/s15010-019-01319-0
123.
Lederberg J. Tatum E. L. (1946 ). Gene recombination in Escherichia coli. Nature 158:558.
Not in our library10.1038/158558a0
124.
Leungtongkam U. Thummeepak R. Tasanapak K. Sitthisak S. (2018 ). Acquisition and transfer of antibiotic resistance genes in association with conjugative plasmid or class 1 integrons of Acinetobacter baumannii. PLoS One 13:e0208468.
Not in our library10.1371/journal.pone.0208468
125.
Lev A. I. Astashkin E. I. Shaikhutdinova R. Z. Platonov M. E. Kartsev N. N. Volozhantsev N. V. (2017 ). Identification of IS1R and IS10R elements inserted into ompk36 porin gene of two multidrug-resistant Klebsiella pneumoniae hospital strains. FEMS Microbiol. Lett. 364:fnx072.
Not in our library10.1093/femsle/fnx072
126.
Characterization of CRISPR-Cas Systems in Clinical Klebsiella pneumoniae Isolates Uncovers Its Potential Association With Antibiotic Susceptibility · 2018
Not checked
127.
Li T. Liang W. Xiao X. Qian Y. (2018 ). Nanotechnology, an alternative with promising prospects and advantages for the treatment of cardiovascular diseases. Int. J. Nanomed. 13 7349–7362.
Not in our library10.2147/ijn.s179678
128.
Lin A. Jimenez J. Derr J. Vera P. Manapat M. L. Esvelt K. M. (2011 ). Inhibition of bacterial conjugation by phage M13 and its protein g3p: quantitative analysis and model. PLoS One 6:e19991.
Not in our library10.1371/journal.pone.0019991
129.
Lin D. M. Koskella B. Lin H. C. (2017 ). Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J. Gastrointest. Pharmacol. Therapeut. 8 162–173.
Not in our library10.4292/wjgpt.v8.i3.162
130.
Liu J. Yang L. Chen D. Peters B. M. Li L. Li B. (2018 ). Complete sequence of pBM413, a novel multidrug resistance megaplasmid carrying qnrVC6 and blaIMP-45 from pseudomonas aeruginosa. Int. J. Antimicrob. Agents 51 145–150.
Not in our library10.1016/j.ijantimicag.2017.09.008
131.
Liu Q. Jiang Y. Shao L. Yang P. Sun B. Yang S. (2017 ). CRISPR/Cas9-based efficient genome editing in Staphylococcus aureus. Acta Biochim. Biophys. Sin. 49 764–770.
Not in our library10.1093/abbs/gmx074
132.
Curing of plasmid pXO1 from Bacillus anthracis using plasmid incompatibility. · 2012
Not checked
133.
Liu Y. Y. Wang Y. Walsh T. R. Yi L. X. Zhang R. Spencer J. (2016 ). Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16 161–168.
Not in our library10.1016/s1473-3099(15)00424-7
134.
Llosa M. Gomis-Ruth F. X. Coll M. de la Cruz F. F. (2002 ). Bacterial conjugation: a two-step mechanism for DNA transport. Mol. Microbiol. 45 1–8.
Not in our library10.1046/j.1365-2958.2002.03014.x
135.
Lujan S. A. Guogas L. M. Ragonese H. Matson S. W. Redinbo M. R. (2007 ). Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase. Proc. Natl. Acad. Sci. U.S.A. 104 12282–12287.
Not in our library10.1073/pnas.0702760104
136.
Maddocks S. Fabijan A. P. Ho J. Lin R. C. Y. Ben Zakour N. L. Dugan C. (2019 ). Bacteriophage therapy of ventilator-associated Pneumonia and Empyema caused by Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med. 200 1179–1181.
Not in our library10.1164/rccm.201904-0839le
137.
Magot M. (1983 ). MTransfer of antibiotic resistances from Clostridium innocuum to Clostridium perfringens in the absence of detectable plasmid DNA. FEMS Microbiol. Lett. 18 149–151.
Not in our library
138.
Mahillon J. Chandler M. (1998 ). Insertion sequences. Microbiol. Mol. Biol. Rev. 62 725–774.
Not in our library10.1128/mmbr.62.3.725-774.1998
139.
Maier L. Pruteanu M. Kuhn M. Zeller G. Telzerow A. Anderson E. E. (2018 ). Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555 623–628.
Not in our library10.1038/nature25979
140.
Makarova K. S. Koonin E. V. (2015 ). Annotation and classification of CRISPR-Cas systems. Methods Mol. Biol. 1311 47–75.
Not in our library10.1007/978-1-4939-2687-9_4
141.
Marraffini L. A. Sontheimer E. J. (2008 ). CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322 1843–1845.
Not in our library10.1126/science.1165771
142.
Marraffini L. A. Sontheimer E. J. (2010 ). CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat. Rev. Genet. 11 181–190.
Not in our library10.1038/nrg2749
143.
Mata C. Navarro F. Miro E. Walsh T. R. Mirelis B. Toleman M. (2011 ). Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis. J. Antimicrob. Chemother. 66 2266–2270.
Not in our library10.1093/jac/dkr286
144.
Mays T. D. Smith C. J. Welch R. A. Delfini C. Macrina F. L. (1982 ). Novel antibiotic resistance transfer in Bacteroides. Antimicrob. Agents Chemother. 21 110–118.
Not in our library10.1128/aac.21.1.110
145.
Mazel D. (2006 ). Integrons: agents of bacterial evolution. Nat. Rev. Microbiol. 4 608–620.
Not in our library10.1038/nrmicro1462
146.
Merril C. R. Scholl D. Adhya S. L. (2003 ). The prospect for bacteriophage therapy in Western medicine. Nat. Rev. Drug Discov. 2 489–497.
Not in our library10.1038/nrd1111
147.
Mesas J. M. Rodriguez M. C. Alegre M. T. (2004 ). Plasmid curing of Oenococcus oeni. Plasmid 51 37–40.
Not in our library10.1016/s0147-619x(03)00074-x
148.
Michel-Briand Y. Laporte J. M. (1985 ). Inhibition of conjugal transfer of R plasmids by nitrofurans. J. Gen. Microbiol. 131 2281–2284.
Not in our library10.1099/00221287-131-9-2281
149.
Michel-Briand Y. Uccelli V. Laporte J. M. Plesiat P. (1986 ). Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives. J. Antimicrob. Chemother. 18 667–674.
Not in our library10.1093/jac/18.6.667
150.
Million-Weaver S. Camps M. (2014 ). Mechanisms of plasmid segregation: have multicopy plasmids been overlooked? Plasmid 75 27–36.
Not in our library10.1016/j.plasmid.2014.07.002
151.
Molnar J. Foldeak S. Nakamura M. J. Rausch H. Domonkos K. Szabo M. (1992 ). Antiplasmid activity: loss of bacterial resistance to antibiotics. APMIS Suppl. 30 24–31.
Not in our library
152.
Molnar J. Mandi Y. Kiraly J. (1976 ). Antibacterial effect of some phenothiazine compounds and R-factor elimination by chlorpromazine. Acta Microbiol. Acad. Sci. Hungar. 23 45–54.
Not in our library
153.
Mugnier P. D. Poirel L. Nordmann P. (2009 ). Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii. J. Bacteriol. 191 2414–2418.
Not in our library10.1128/jb.01258-08
154.
Nandi S. Maurer J. J. Hofacre C. Summers A. O. (2004 ). Gram-positive bacteria are a major reservoir of Class 1 antibiotic resistance integrons in poultry litter. Proc. Natl. Acad. Sci. U.S.A. 101 7118–7122.
Not in our library10.1073/pnas.0306466101
155.
Nejdl L. Kudr J. Moulick A. Hegerova D. Ruttkay-Nedecky B. Gumulec J. (2017 ). Platinum nanoparticles induce damage to DNA and inhibit DNA replication. PLoS One 12:e0180798.
Not in our library10.1371/journal.pone.0180798
156.
Ni B. Du Z. Guo Z. Zhang Y. Yang R. (2008 ). Curing of four different plasmids in Yersinia pestis using plasmid incompatibility. Lett. Appl. Microbiol. 47 235–240.
Not in our library10.1111/j.1472-765x.2008.02426.x
157.
Nishi A. Tominaga K. Furukawa K. (2000 ). A 90-kilobase conjugative chromosomal element coding for biphenyl and salicylate catabolism in Pseudomonas putida KF715. J. Bacteriol. 182 1949–1955.
Not in our library10.1128/jb.182.7.1949-1955.2000
158.
Nordmann P. Poirel L. (2002 ). Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8 321–331.
Not in our library10.1046/j.1469-0691.2002.00401.x
159.
Nordstrom K. (2006 ). Plasmid R1–replication and its control. Plasmid 55 1–26.
Not in our library10.1016/j.plasmid.2005.07.002
160.
Novick R. P. (1987 ). Plasmid incompatibility. Microbiol. Rev. 51 381–395.
Not in our library10.1128/mr.51.4.381-395.1987
161.
Ojo S. K. Sargin B. O. Esumeh F. I. (2014 ). Plasmid curing analysis of antibiotic resistance in beta-lactamase producing Staphylococci from wounds and burns patients. PJBS 17 130–133.
Not in our library10.3923/pjbs.2014.130.133
162.
Olliver A. Valle M. Chaslus-Dancla E. Cloeckaert A. (2005 ). Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones. Antimicrob. Agents Chemother. 49 289–301.
Not in our library10.1128/aac.49.1.289-301.2005
163.
Bacteriophage Application for Difficult-To-Treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol · 2019
No notice
164.
Partridge S. R. (2011 ). Analysis of antibiotic resistance regions in Gram-negative bacteria. FEMS Microbiol. Rev. 35 820–855.
Not in our library10.1111/j.1574-6976.2011.00277.x
165.
Partridge S. R. Kwong S. M. Firth N. Jensen S. O. (2018 ). Mobile genetic elements associated with antimicrobial resistance. Clin. Microbiol. Rev. 31:e00088-17.
Not in our library10.1128/cmr.00088-17
166.
Partridge S. R. Tsafnat G. Coiera E. Iredell J. R. (2009 ). Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiol. Rev. 33 757–784.
Not in our library10.1111/j.1574-6976.2009.00175.x
167.
Pelgrift R. Y. Friedman A. J. (2013 ). Nanotechnology as a therapeutic tool to combat microbial resistance. Adv. Drug Deliv. Rev. 65 1803–1815.
Not in our library10.1016/j.addr.2013.07.011
168.
Pembroke J. T. MacMahon C. McGrath B. (2002 ). The role of conjugative transposons in the Enterobacteriaceae. Cell. Mol. Life Sci. 59 2055–2064.
Not in our library10.1007/s000180200005
169.
Penes N. O. Muntean A. A. Moisoiu A. Muntean M. M. Chirca A. Bogdan M. A. (2017 ). An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania. Roman. J. Morphol. Embryol. 58 909–922.
Not in our library
170.
Pinilla-Redondo R. Cyriaque V. Jacquiod S. Sorensen S. J. Riber L. (2018 ). Monitoring plasmid-mediated horizontal gene transfer in microbiomes: recent advances and future perspectives. Plasmid 99 56–67.
Not in our library10.1016/j.plasmid.2018.08.002
171.
Ponce-Rivas E. Munoz-Marquez M. E. Khan A. A. (2012 ). Identification and molecular characterization of class 1 integrons in multiresistant Escherichia coli isolates from poultry litter. Appl. Environ. Microbiol. 78 5444–5447.
Not in our library10.1128/aem.00660-12
172.
Poole K. (2017 ). At the nexus of antibiotics and metals: the impact of Cu and Zn on antibiotic activity and resistance. Trends Microbiol. 25 820–832.
Not in our library10.1016/j.tim.2017.04.010
173.
Posno M. Leer R. J. van Luijk N. van Giezen M. J. Heuvelmans P. T. Lokman B. C. (1991 ). Incompatibility of Lactobacillus vectors with replicons derived from small cryptic Lactobacillus plasmids and segregational instability of the introduced vectors. Appl. Environ. Microbiol. 57 1822–1828.
Not in our library10.1128/aem.57.6.1822-1828.1991
174.
Pourcel C. Salvignol G. Vergnaud G. (2005 ). CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 151(Pt 3), 653–663.
Not in our library10.1099/mic.0.27437-0
175.
Price V. J. McBride S. W. Hullahalli K. Chatterjee A. Duerkop B. A. Palmer K. L. (2019 ). Enterococcus faecalis CRISPR-Cas is a robust barrier to conjugative antibiotic resistance dissemination in the murine intestine. mSphere 4:e00464-19.
Not in our library10.1128/msphere.00464-19
176.
Pulcrano G. Pignanelli S. Vollaro A. Esposito M. Iula V. D. Roscetto E. (2016 ). Isolation of Enterobacter aerogenes carrying blaTEM-1 and blaKPC-3 genes recovered from a hospital Intensive Care Unit. APMIS 124 516–521.
Not in our library10.1111/apm.12528
177.
Rai M. K. Deshmukh S. D. Ingle A. P. Gade A. K. (2012 ). Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J. Appl. Microbiol. 112 841–852.
Not in our library10.1111/j.1365-2672.2012.05253.x
178.
Raja C. Selvam G. (2009 ). Plasmid profile and curing analysis of Pseudomonas aeruginosa as metal resistant. Int. J. Environ. Sci. Technol. 6 259–266.
Not in our library
179.
Rajpara N. Nair M. Chowdhury G. Mukhopadhyay A. K. Ramamurthy T. Niyogi S. K. (2018 ). Molecular analysis of multidrug resistance in clinical isolates of Shigella spp. from 2001-2010 in Kolkata. India: role of integrons, plasmids, and topoisomerase mutations. Infect. Drug Resist. 11 87–102.
Not in our library10.2147/idr.s148726
180.
Rankin D. J. Rocha E. P. Brown S. P. (2011 ). What traits are carried on mobile genetic elements, and why? Heredity 106 1–10.
Not in our library10.1038/hdy.2010.24
181.
Ravatn R. Studer S. Springael D. Zehnder A. J. van der Meer J. R. (1998 ). Chromosomal integration, tandem amplification, and deamplification in Pseudomonas putida F1 of a 105-kilobase genetic element containing the chlorocatechol degradative genes from Pseudomonas sp. Strain B13. J. Bacteriol. 180 4360–4369.
Not in our library10.1128/jb.180.17.4360-4369.1998
182.
Recchia G. D. Hall R. M. (1995 ). Gene cassettes: a new class of mobile element. Microbiology 141(Pt 12), 3015–3027.
Not in our library10.1099/13500872-141-12-3015
183.
Riber L. Burmolle M. Alm M. Milani S. M. Thomsen P. Hansen L. H. (2016 ). Enhanced plasmid loss in bacterial populations exposed to the antimicrobial compound irgasan delivered from interpenetrating polymer network silicone hydrogels. Plasmid 8 72–78.
Not in our library10.1016/j.plasmid.2016.10.001
184.
Roberts A. P. Chandler M. Courvalin P. Guedon G. Mullany P. Pembroke T. (2008 ). Revised nomenclature for transposable genetic elements. Plasmid 60 167–173.
Not in our library10.1016/j.plasmid.2008.08.001
185.
Roberts A. P. Mullany P. (2009 ). A modular master on the move: the Tn916 family of mobile genetic elements. Trends Microbiol. 17 251–258.
Not in our library10.1016/j.tim.2009.03.002
186.
Roberts M. C. Smith A. L. (1980 ). Molecular characterization of “plasmid-free” antibiotic-resistant Haemophilus influenzae. J. Bacteriol. 144 476–479.
Not in our library10.1128/jb.144.1.476-479.1980
187.
Roche D. Flechard M. Lallier N. Reperant M. Bree A. Pascal G. (2010 ). ICEEc2, a new integrative and conjugative element belonging to the pKLC102/PAGI-2 family, identified in Escherichia coli strain BEN374. J. Bacteriol. 192 5026–5036.
Not in our library10.1128/jb.00609-10
188.
Rosenberg C. Boistard P. Denarie J. Casse-Delbart F. (1981 ). Genes controlling early and late functions in symbiosis are located on a megaplasmid in Rhizobium meliloti. Mol. Gen. Genet. 184 326–333.
Not in our library10.1007/bf00272926
189.
Ruiz-Martinez L. Lopez-Jimenez L. d’Ostuni V. Fuste E. Vinuesa T. Vinas M. (2011 ). A mechanism of carbapenem resistance due to a new insertion element (ISPa133) in Pseudomonas aeruginosa. Int. Microbiol. 14 51–58.
Not in our library10.2436/20.1501.01.135
190.
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens · 2016
No notice
191.
Santo C. E. Morais P. V. Grass G. (2010 ). Isolation and characterization of bacteria resistant to metallic copper surfaces. Appl. Environ. Microbiol. 76 1341–1348.
Not in our library10.1128/aem.01952-09
192.
Sarker S. A. Sultana S. Reuteler G. Moine D. Descombes P. Charton F. (2016 ). Oral phage therapy of acute bacterial diarrhea with two Coliphage preparations: a randomized trial in children from Bangladesh. EBiomedicine 4 124–137.
Not in our library10.1016/j.ebiom.2015.12.023
193.
Schairer D. O. Chouake J. S. Nosanchuk J. D. Friedman A. J. (2012 ). The potential of nitric oxide releasing therapies as antimicrobial agents. Virulence 3 271–279.
Not in our library10.4161/viru.20328
194.
Schmidt H. Hensel M. (2004 ). Pathogenicity islands in bacterial pathogenesis. Clin. Microbiol. Rev. 17 14–56.
Not in our library10.1128/cmr.17.1.14-56.2004
195.
Schooley R. T. Biswas B. Gill J. J. Hernandez-Morales A. Lancaster J. Lessor L. (2017 ). Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 61
Not in our library10.1128/aac.02221-18
196.
Seal B. S. Drider D. Oakley B. B. Brussow H. Bikard D. Rich J. O. (2018 ). Microbial-derived products as potential new antimicrobials. Vet. Res. 49:66.
Not in our library10.1186/s13567-018-0563-5
197.
Selan L. Scazzocchio F. Oliva B. Schippa S. Allocati N. Renzini G. (1988 ). Plasmid “curing” by some recently synthetized 4-quinolone compounds. Chemioterapia 7 292–294.
Not in our library
198.
Shapiro J. A. (1985 ). Mechanisms of DNA reorganization in bacteria. Int. Rev. Cytol. 93 25–56.
Not in our library10.1016/s0074-7696(08)61371-6
199.
Insertional inactivation of oprD in carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in Tehran, Iran · 2018
Not checked
200.
Shi L. Liang Q. Feng J. Zhan Z. Zhao Y. Yang W. (2018 ). Coexistence of two novel resistance plasmids, blaKPC-2-carrying p14057A and tetA(A) -carrying p14057B, in Pseudomonas aeruginosa. Virulence 9 306–311.
Not in our library10.1080/21505594.2017.1372082
201.
Genomics of microbial plasmids: classification and identification based on replication and transfer systems and host taxonomy · 2015
No notice
202.
Shlaes D. M. Gerding D. N. John J. F. Jr. Craig W. A. Bornstein D. L. Duncan R. A. (1997 ). Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin. Infect. Dis. 25 584–599.
Not in our library10.1086/513766
203.
Shoemaker N. B. Smith M. D. Guild W. R. (1980 ). DNase-resistant transfer of chromosomal cat and tet insertions by filter mating in Pneumococcus. Plasmid 3 80–87.
Not in our library10.1016/s0147-619x(80)90036-0
204.
Shokoohizadeh L. Mobarez A. M. Zali M. R. Ranjbar R. Alebouyeh M. Sakinc T. (2013 ). High frequency distribution of heterogeneous vancomycin resistant Enterococcous faecium (VREfm) in Iranian hospitals. Diagn. Pathol. 8:163.
Not in our library10.1186/1746-1596-8-163
205.
Siguier P. Gourbeyre E. Varani A. Ton-Hoang B. Chandler M. (2015 ). Everyman’s guide to bacterial insertion sequences. Microbiol. Spectr. 3:MDNA3-0030-2014.
Not in our library10.1128/microbiolspec.mdna3-0030-2014
206.
Siguier P. Perochon J. Lestrade L. Mahillon J. Chandler M. (2006 ). ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 34 D32–D36.
Not in our library10.1093/nar/gkj014
207.
Silva L. Mourao J. Grosso F. Peixe L. (2018 ). Uncommon carbapenemase-encoding plasmids in the clinically emergent Acinetobacter pittii. J. Antimicrob. Chemother. 73 52–56.
Not in our library10.1093/jac/dkx364
208.
Smillie C. Garcillan-Barcia M. P. Francia M. V. Rocha E. P. de la Cruz F. (2010 ). Mobility of plasmids. Microbiology and molecular biology reviews. MMBR 74 434–452.
Not in our library10.1128/mmbr.00020-10
209.
So Y. Park S. Y. Park E. H. Park S. H. Kim E. J. Pan J. G. (2017 ). A Highly efficient CRISPR-Cas9-mediated large genomic deletion in Bacillus subtilis. Front. Microbiol. 8:1167.
Not in our library10.3389/fmicb.2017.01167
210.
Sonstein S. A. Baldwin J. N. (1972 ). Nature of the elimination of the penicillinase plasmid from Staphylococcus aureus by surface-active agents. J. Bacteriol. 111 152–155.
Not in our library10.1128/jb.111.1.152-155.1972
211.
Stanisich V. A. (1988 ). “Identification and analysus of plasmids at the genetic level,” in Methods in Microbiology Vol 21 Plasmid Technology, 2nd Edn, eds Grinsted J. Bennett P. M. (London: Academic Press), 11–47.
Not in our library
212.
Antibiotics, Resistome and Resistance Mechanisms: A Bacterial Perspective · 2018
No notice
213.
Summers W. C. (2004 ). “Bacteriophage research: early history,” in Bacteriophages: Biology And Applications, 1 Edn, eds Kutter E. Sulakvelidze A. (Boca Raton, FL: CRC Press), 5–27.
Not in our library
214.
Sun L. He T. Zhang L. Pang M. Zhang Q. Zhou Y. (2017 ). Generation of newly discovered resistance gene mcr-1 Knockout in Escherichia coli using the CRISPR/Cas9 system. J. Microbiol. Biotechnol. 27 1276–1280.
Not in our library10.4014/jmb.1611.11021
215.
Taylor V. L. Fitzpatrick A. D. Islam Z. Maxwell K. L. (2019 ). The diverse impacts of phage morons on bacterial fitness and virulence. Adv. Virus Res. 103 1–31.
Not in our library10.1016/bs.aivir.2018.08.001
216.
Thaden J. T. Li Y. Ruffin F. Maskarinec S. A. Hill-Rorie J. M. Wanda L. C. (2017 ). Increased costs associated with bloodstream infections caused by multidrug-resistant gram-negative bacteria are due primarily to patients with hospital-acquired infections. Antimicrob. Agents Chemother. 61:e0170916.
Not in our library10.1128/aac.01709-16
217.
Thompson J. N. (1994 ). The Coevolutionary Process. Chicago, IL: University of Chicago Press.
Not in our library
218.
Tkhilaishvili T. Winkler T. Muller M. Perka C. Trampuz A. (2019 ). Bacteriophages as adjuvant to antibiotics for the treatment of periprosthetic joint infection caused by multidrug-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 64:AAC.00924-19.
Not in our library10.1128/aac.00924-19
219.
Toleman M. A. Walsh T. R. (2008 ). Evolution of the ISCR3 group of ISCR elements. Antimicrob. Agents Chemother. 52 3789–3791.
Not in our library10.1128/aac.00479-08
220.
Toleman M. A. Walsh T. R. (2011 ). Combinatorial events of insertion sequences and ICE in Gram-negative bacteria. FEMS Microbiol. Rev. 35 912–935.
Not in our library10.1111/j.1574-6976.2011.00294.x
221.
The disparate effects of bacteriophages on antibiotic-resistant bacteria · 2018
No notice
222.
Upadhyay S. Khyriem A. B. Bhattacharya P. Bhattacharjee A. Joshi S. R. (2018 ). High-level aminoglycoside resistance in Acinetobacter baumannii recovered from Intensive Care Unit patients in Northeastern India. Indian J. Med. Microbiol. 36 43–48.
Not in our library10.4103/ijmm.ijmm_17_225
223.
Uraji M. Suzuki K. Yoshida K. (2002 ). A novel plasmid curing method using incompatibility of plant pathogenic Ti plasmids in Agrobacterium tumefaciens. Genes Genet. Syst. 77 1–9.
Not in our library10.1266/ggs.77.1
224.
Uz Zaman T. Albladi M. Siddique M. I. Aljohani S. M. Balkhy H. H. (2018 ). Insertion element mediated mgrB disruption and presence of ISKpn28 in colistin-resistant Klebsiella pneumoniae isolates from Saudi Arabia. Infect. Drug Resist. 11 1183–1187.
Not in our library10.2147/idr.s161146
225.
Van Boeckel T. P. Gandra S. Ashok A. Caudron Q. Grenfell B. T. Levin S. A. (2014 ). Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect. Dis. 14 742–750.
Not in our library10.1016/s1473-3099(14)70780-7
226.
Reducing antimicrobial use in food animals · 2017
No notice
227.
van der Zee A. Kraak W. B. Burggraaf A. Goessens W. H. F. Pirovano W. Ossewaarde J. M. (2018 ). Spread of carbapenem resistance by transposition and conjugation among Pseudomonas aeruginosa. Front. Microbiol. 9:2057.
Not in our library10.3389/fmicb.2018.02057
228.
van Elsas J. D. Bailey M. J. (2002 ). The ecology of transfer of mobile genetic elements. FEMS Microbiol. Ecol. 42 187–197.
Not in our library10.1111/j.1574-6941.2002.tb01008.x
229.
Vandecraen J. Chandler M. Aertsen A. Van Houdt R. (2017 ). The impact of insertion sequences on bacterial genome plasticity and adaptability. Crit. Rev. Microbiol. 43 709–730.
Not in our library10.1080/1040841x.2017.1303661
230.
Ventola C. L. (2015 ). The antibiotic resistance crisis: part 1: causes and threats. PT 40 277–283.
Not in our library
231.
Walker F. C. Hatoum-Aslan A. (2017 ). Conjugation assay for testing CRISPR-Cas anti-plasmid immunity in Staphylococci. Bio Protoc. 7:e2293.
Not in our library10.21769/bioprotoc.2293
232.
Wang H. Liu X. Feng E. Zhu L. Wang D. Liao X. (2011 ). Curing the plasmid pXO2 from Bacillus anthracis A16 using plasmid incompatibility. Curr. Microbiol. 62 703–709.
Not in our library10.1007/s00284-010-9767-2
233.
Wang L. Hu C. Shao L. (2017 ). The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int. J. Nanomed. 12 1227–1249.
Not in our library10.2147/ijn.s121956
234.
Wang P. He D. Li B. Guo Y. Wang W. Luo X. (2019 ). Eliminating mcr-1-harbouring plasmids in clinical isolates using the CRISPR/Cas9 system. J. Antimicrob. Chemother. 74 2559–2565.
Not in our library10.1093/jac/dkz246
235.
Weisser J. Wiedemann B. (1985 ). Elimination of plasmids by new 4-quinolones. Antimicrob. Agents Chemother. 28 700–702.
Not in our library10.1128/aac.28.5.700
236.
Wigle T. J. Sexton J. Z. Gromova A. V. Hadimani M. B. Hughes M. A. Smith G. R. (2009 ). Inhibitors of RecA activity discovered by high-throughput screening: cell-permeable small molecules attenuate the SOS response in Escherichia coli. J. Biomol. Screen. 14 1092–1101.
Not in our library10.1177/1087057109342126
237.
World Health Organization [WHO] (2017 ). Global Priority list of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. Geneva: WHO.
Not in our library
238.
Wozniak R. A. Waldor M. K. (2010 ). Integrative and conjugative elements: mosaic mobile genetic elements enabling dynamic lateral gene flow. Nat. Rev. Microbiol. 8 552–563.
Not in our library10.1038/nrmicro2382
239.
Xu Y. Xu J. Mao D. Luo Y. (2017 ). Effect of the selective pressure of sub-lethal level of heavy metals on the fate and distribution of ARGs in the catchment scale. Environ. Pollut. 220(Pt B), 900–908.
Not in our library10.1016/j.envpol.2016.10.074
240.
Yazdankhah S. Rudi K. Bernhoft A. (2014 ). Zinc and copper in animal feed - development of resistance and co-resistance to antimicrobial agents in bacteria of animal origin. Microb. Ecol. Health Dis. 25:25862.
Not in our library10.3402/mehd.v25.25862
241.
Yosef I. Manor M. Kiro R. Qimron U. (2015 ). Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc. Natl. Acad. Sci. U.S.A. 112 7267–7272.
Not in our library10.1073/pnas.1500107112
242.
Yuan Y. Wang L. Li X. Tan D. Cong C. Xu Y. (2019 ). Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii. Virus Res. 272:197734.
Not in our library10.1016/j.virusres.2019.197734
243.
Zaman M. Pasha M. Akhter M. (2010 ). Plasmid curing of Escherichia coli cells with ethidium bromide, sodium dodecyl sulfate and acridine orange. Bangladesh J. Microbiol. 1 28–31.
Not in our library
244.
Zhang L. Pornpattananangku D. Hu C. M. Huang C. M. (2010 ). Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem. 17 585–594.
Not in our library10.2174/092986710790416290

Cited by papers we hold 5

Unraveling the role of mobile genetic elements in antibiotic resistance transmission and defense strategies in bacteria · 2025
Not checked
Mobilome-driven segregation of the resistome in biological wastewater treatment · 2022
Not checked
The Spread of Antibiotic Resistance Genes In Vivo Model · 2022
No notice
Antibiotic-Resistant Bacteria in Aquaculture and Climate Change: A Challenge for Health in the Mediterranean Area · 2021
No notice
Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii · 2020
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.